Stay updated on XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa
Sign up to get notified when there's something new on the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page.

Latest updates to the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page
- CheckyesterdayChange DetectedThe page displays the ClinicalTrials.gov record for an observational study of X-linked retinitis pigmentosa, including its eligibility criteria, locations, study design, outcome measures, and record dates.SummaryDifference35%

- Check8 days agoChange DetectedThe site footer revision identifier changed from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study record page now shows a 403 Forbidden error with a Home link rather than its prior blank main content area.SummaryDifference0.5%

Stay in the know with updates to XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa
Enter your email address, and we'll notify you when there's something new on the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page.